China National Medicines Corporation Ltd.

Shanghai Stock Exchange 600511.SS

China National Medicines Corporation Ltd. Inventory for the year ending December 31, 2023: USD 557.97 M

China National Medicines Corporation Ltd. Inventory is USD 557.97 M for the year ending December 31, 2023, a 3.58% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

China National Medicines Corporation Ltd. Inventory for the year ending December 31, 2022 was USD 538.69 M, a -2.62% change year over year.
China National Medicines Corporation Ltd. Inventory for the year ending December 31, 2021 was USD 553.19 M, a 18.41% change year over year.
China National Medicines Corporation Ltd. Inventory for the year ending December 31, 2020 was USD 467.19 M, a -3.07% change year over year.
China National Medicines Corporation Ltd. Inventory for the year ending December 31, 2019 was USD 481.99 M, a -0.85% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Shanghai Stock Exchange: 600511.SS

China National Medicines Corporation Ltd.

CEO	Mr. Guotao Tian
IPO Date	Nov. 27, 2002
Location	China
Headquarters	No. 12 A, Sanyuan West Alley
Employees	3,138
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

Key trends

Past 5 years